The short version
- Why people research itFocus, memory, neuroprotection, mood and stress resilience.
- What the evidence isNo controlled trial has been run in a healthy adult, and every trial is Russian-language and single-country.
- What to watchVomiting, lethargy or confusion.
How Hopantenic Acid works
Pantothenic acid with the beta-alanine replaced by GABA — one methylene group away from vitamin B5, which is exactly the problem and exactly the selling point. As a GABA analog with a bulky polar tail it is described as a weak GABA-B ligand, which is the nootropic story. As a pantothenate analog it competes with vitamin B5 for the pathway that builds coenzyme A, which is the story behind the only serious toxicity ever recorded for this family: a Japanese case series of acute encephalopathy with metabolic acidosis and severe hypoglycemia during calcium hopantenate.
One methylene group from vitamin B5, and that is both the mechanism and the toxicity. Pantothenic acid is beta-alanine joined to pantoic acid.
The nootropic reading. Attaching the pantoyl group to GABA makes a molecule that crosses membranes better than GABA itself, which is essentially excluded from the brain. It is described as a weak ligand at GABA-B receptors, and Chen 2019 reviews what GABA signaling does in ischemia and reperfusion in brain and peripheral organs — the context most of the Russian clinical work sits in.
- Oral
On the goal map: Cerebral metabolism & blood flow (Focus, memory & cognition)
Research on Hopantenic Acid8 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: A registered medicine in Russia and neighboring countries; unapproved everywhere else. Every controlled trial is Russian-language, and most are in children.
Human clinical evidence
Two multicenter double-blind placebo-controlled trials exist and both are in children: hopantenic acid in attention deficit hyperactivity disorder over four months (Zavadenko 2017), reporting improvement in 63.6% of treated patients (Zavadenko 2019).
The adult studies use the racemate and are in diagnosed populations: cognitive and anxiety disorders in arterial hypertension (Smulevich 2015), and anxiety and depressive disorders in chronic cerebral ischemia (Gekht 2016).
No controlled trial has been run in a healthy adult, and every trial is Russian-language and single-country.
No completed human trial
Correlative data
GABA signaling in ischemia and reperfusion, in brain and peripheral organs, is the context most of that clinical work sits in (Chen 2019).
The one documented serious toxicity in this family: five patients with acute encephalopathy, marked metabolic acidosis and severe hypoglycemia during calcium hopantenate administration, attributed to interference with coenzyme A synthesis (Ohsuga 1989).
How the mechanism reads
It is pantothenic acid with the beta-alanine replaced by GABA — one methylene group from vitamin B5, which is simultaneously the nootropic story and the toxicity story.
MechanisticAs a pantothenate analog it competes for incorporation into coenzyme A, which fatty acid oxidation and carnitine-dependent transport both require. That chain is the proposed pathogenesis of the 1989 series.
MechanisticThe three brands are not three brands of one drug. PANTOGAM is the calcium salt of the D-isomer; PANTOGAM ACTIVE is the racemate, a different composition with its own trials; PANTOCALCIN is calcium hopantenate again.
Mechanistic
Sources
- Zavadenko NN, Suvorinova NY, Vakula IN, Malinina EV, Kuzenkova LM. [Pharmacotherapy of attention deficit hyperactivity disorder in children: the results of a multicenter double-blind placebo-controlled study of hopantenic acid]. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 2017 [Russian] · PMID 28638029
- Zavadenko NN, Guzeva VI, Gaynetdinova DD, Davydova LA, Zavadenko AN, Romanova TA. [Pharmacotherapy of psychomotor developmental delay in 6-12 months preterm infants with hypoxic-ischemic encephalopathy (the double-blind comparative multicenter placebo-controlled study)]. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 2019 [Russian] · PMID 31793540
- Smulevich AB, Volel BA, Ternovaya ES, Nikitina YM. [Pantogam activ (D-, L-hopantenic acid) in the treatment of cognitive and anxiety disorders in patients with arterial hypertension]. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 2015 [Russian] · PMID 26978493
- Gekht AB, Kanaeva LS, Avedisova AS, Marachev MP, Zakharova KV, Dashkina GK, Kulikova EV. [Possible applications of rac-hopantenic acid in the treatment of anxiety and depressive disorders in patients with chronic cerebral ischemia]. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 2016 [Russian] · PMID 28091501
- Ohsuga S, Ohsuga H, Takeoka T, Ikeda A, Shinohara Y. [Metabolic acidosis and hypoglycemia during calcium hopantenate administration--report on 5 patients]. Rinsho Shinkeigaku 1989 [Japanese] · PMID 2582687
- Chen C, Zhou X, He J, Xie Z, Xia S, Lu G. The Roles of GABA in Ischemia-Reperfusion Injury in the Central Nervous System and Peripheral Organs. Oxidative Medicine and Cellular Longevity 2019 · PMID 31814874
Hopantenic Acid safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Children, since the documented encephalopathy cases involved young patients.
- Carnitine deficiency or a fatty-acid oxidation disorder.
- Fasting, low-carb eating or any state where fat oxidation is relied on for glucose.
- Liver disease, where fat oxidation and glucose output are already fragile.
- Pregnancy, given the pantothenate-pathway interference.
What’s expected
- Calm focus from a weak GABA-B ligand.
- Sleepiness in some.
- Lower coenzyme A availability if it competes with pantothenic acid.
Watch for
- Vomiting, lethargy or confusion.
- Shakiness or sweating from low blood sugar.
- Rapid breathing, a sign of metabolic acidosis.
Labs that tell you it’s working
- Carnitine, Total and Free: a fall signals the fat-oxidation drain behind the documented toxicity.
- Vitamin B5 (Pantothenic Acid): the molecule it mimics, so a shift shows competition.
- Comprehensive Metabolic Panel: bicarbonate and glucose capture acidosis and hypoglycemia.
Pantothenic acid analog with GABA replacing beta-alanine: weak GABA-B ligand that can disrupt CoA synthesis, causing acidosis and low glucose. PMID 2582687
Also on the record
- Not an approved drug in the US. The calcium salt of the same acid was associated with a series of acute encephalopathy cases with metabolic acidosis and severe hypoglycemia, attributed to competition with vitamin B5 for coenzyme A synthesis.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Hopantenic Acid FAQ4 common questions
- Is Hopantenic Acid approved for human use?
- Hopantenic Acid is an approved medicine for the uses on its label. This page covers research beyond those uses, as education, not medical advice.
- What is Hopantenic Acid researched for?
- Focus, memory, neuroprotection, mood and stress resilience.
- Which labs show whether it's doing anything?
- Carnitine, Total and Free; Vitamin B5; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Hopantenic Acid: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



